DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación
Otros (Other)
A genetic map of the response to DNA damage in human cells
Versión postprint próximamente disponible en: http://hdl.handle.net/10261/228202, The response to DNA damage is critical for cellular homeostasis, tumor suppression,
immunity and gametogenesis. In order to provide an unbiased and global view of the DNA
damage response in human cells, we undertook 28 CRISPR/Cas9 screens against 25 genotoxic
agents in the retinal pigment epithelium-1 (RPE1) cell line. These screens identified 840 genes
whose loss causes either sensitivity or resistance to DNA damaging agents. Mining this dataset,
we uncovered that ERCC6L2, which is mutated in a bone-marrow failure syndrome, codes for
a canonical non-homologous end-joining pathway factor; that the RNA polymerase II
component ELOF1 modulates the response to transcription-blocking agents and that the
cytotoxicity of the G-quadruplex ligand pyridostatin involves trapping topoisomerase II on
DNA. This map of the DNA damage response provides a rich resource to study this
fundamental cellular system and has implications for the development and use of genotoxic
agents in cancer therapy., AAQ, GSM and AMH are recipients of long-term EMBO fellowships (ALTF 910-2017, 795-2017 under a CC-BY-NC-ND 4.0 International license.
not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available
bioRxiv preprint doi: https://doi.org/10.1101/845446; this version posted November 18, 2019. The copyright holder for this preprint (which was
27
and 124-2019, respectively), NH was supported by a Human Frontier Science Program long-term
Fellowship, SER is supported by a fellowship from AIRC and SA was a Banting post-doctoral
fellow. ASB was supported by a PhD Studentship from AEFAT (Asociación Española Familia
Ataxia Telangiectasia) and an EMBO short-term fellowship for a visit to the DD laboratory. The
ICRF187 screen in FCL laboratory was funded by grants from the Spanish Government (SAF2017-
89619-R, European Regional Development Fund) and the European Research Council (ERC-CoG2014-647359). Work in the RSW laboratory was supported in part by the US National Institute of
Health Intramural Program, US National Institute of Environmental Health Sciences (NIEHS,
1Z01ES102765). DD is a Canada Research Chair (Tier I) and the work was supported from grants
from the CIHR (FDN143343 to DD; FRN 123518, PJT-156330 to AM) Canadian Cancer Society
grant 705644 (to DD) with additional support to DD from the Krembil Foundation., No